Pinterest • The world’s catalogue of ideas

Shares of Dr Reddy's Laboratories added 1.3 percent intraday Monday after the drug maker launched HAiROOTZ. - See more at: http://ways2capital.blogspot.in/2015/06/dr-reddys-labs-climbs-on-hair-growth.html#sthash.CGEFA6hN.dpuf

1

Dr. Reddy’s Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829

Dr. Reddy's Laboratories (BSE: NSE: DRREDDY, NYSE: RDY) and XenoPort, Inc. (NASDAQ: XNPT) announced today that they have entered into a licens

Dr Reddy's Laboratories submitted a response to the US health regulator on a warning letter it had received last month. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/dr-reddys-submits-response-to-usfda-on.html#sthash.cHBBZ00E.dpuf

Dr Reddy's Laboratories, Japan's Eisai ink licensing pact for anticancer agent | ET HealthWorld

Shares of Dr Reddy's Laboratories rose 1.8 percent to touch a life high of Rs 3,827.10 on the Bombay Stock Exchange Tuesday. - See more at: http://ways2capital-review.blogspot.in/2015/07/dr-reddys-hits-new-high-on-alzheimers.html#sthash.UTGluNQo.dpuf

1

The S&P BSE Sensex started on a cautious note on Wednesday following muted trend seen in other Asian markets. The fall in the index was led by losses in Dr Reddy's Laboratories, HDFC, Bharti Airtel, and ICICI Bank. Get Expert Advice for Stock and Commodity Market Trading www.marketmagnify.com/stock-cash-tips.php

Dr. Reddy's Laboratories announced today that it has entered into a licensing agreement with Eisai Co., Ltd, Japan by which Dr. Reddy's - See more at: http://ways2capital-equitytips.blogspot.in/2016/03/dr-reddys-acquires-e7777s-rights-from.html#sthash.xu9xy51H.dpuf